Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Join the club for FREE to access the whole archive and other member benefits.
Sr. Vice President, Basic Science at Roswell Park Cancer Institute
Andrei V. Gudkov, PhD, DSci, a pre-eminent cancer researcher was appointed Senior Vice President, Research Technology and Innovation; Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant at Roswell Park Comprehensive Cancer Center in 2007. He is responsible for building on the basic and translational research strengths of the Cell Stress Biology program in DNA damage and repair, photodynamic therapy, thermal and hypoxic stress and immune modulation. As Senior Vice President, he will assist the President & CEO in developing and implementing strategic plans for new scientific programs and enhance collaborations in research programs with regional and national academic centers as well as with industry.
Before joining Roswell Park, Dr. Gudkov served as chair of the Department of Molecular Genetics at Lerner Research Institute, Cleveland Clinic Foundation, and professor of biochemistry at Case Western University. He earned his doctoral degree in Experimental Oncology at the Cancer Research Center, USSR and a Doctorate of Science (D.Sci) in Molecular Biology at the Moscow State University, USSR. He has authored or co-authored 135 scientific articles and holds 27 patents.
Visit website: https://www.roswellpark.org/andrei-gudkov
See also: Roswell Park Comprehensive Cancer Center - First center in USA focused on cancer research and treatment
Details last updated 09-Sep-2020
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
02-Sep-2022 to 03-Sep-2022
Science and Education virtual conference organized by SENS Research Foundation (FREE)
Key points from 20 presentations from world-leading researchers
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
More and more companies making greater and greater progress - 2021 could be an exciting year